logo.jpg
Processa Pharmaceuticals Announces Closing of $7.0 Million Public Offering
01 févr. 2024 16h22 HE | Processa Pharmaceuticals, Inc.
HANOVER, MD, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next...